consolidation durvalumab could be new soc in limited-stage sclc
Published 5 months ago • 975 plays • Length 5:08Download video MP4
Download video MP3
Similar videos
-
4:33
durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...
-
5:28
adriatic from esmo 2024 - durvalumab as consolidation in limited-stage sclc with updates on pci
-
![[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital](https://i.ytimg.com/vi/EwpYIgllxqY/mqdefault.jpg)
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
39:06
durvalumab after ct rt in limited stage sclc journal club
-
6:22
refining which patients benefit from consolidation durvalumab for stage iii unresectable nsclc
-
3:59
the adriatic trial in limited-stage sclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
1:29
how can durvalumab be used in nsclc?
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
5:28
durvalumab consolidation in nsclc: the pacific trial
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
7:44
durvalumab (imfinzi) fda approved for stage iii nsclc: standard of care? (bmic-024)
-
2:14
pacific-6: durvalumab after chemoradiotherapy in unresectable stage iii nsclc | crsf
-
3:31
expert comment: caspian trial of durvalumab in sclc | raffaele califano
-
3:25
impact of radiation dose to immune cells in unresectable or stage iii nsclc in the durvalumab era
-
2:07
extensive-stage sclc: potential in the caspian trial
-
3:07
the use of durvalumab in locally advanced nsclc
-
6:20
immunotherapy in stage iii nsclc: practice-changing results of pacific trial (bmic-006)
-
11:30
durvalumab following radiotherapy in patients with unresectable, stage 3 nsclc ineligible for ch...